APEX Biologix Enters Exclusive U.S. Distribution Agreement with Bioventus LLC for XCELL PRP® System
Clearwater, FL - May 20, 2025 - APEX Biologix, a leading provider of advanced biologic interventions and regenerative medicine solutions, is pleased to announce an exclusive distribution agreement with Bioventus for the XCELL PRP system throughout the United States for orthopedics and sports medicine. This collaboration utilizes one of APEX Biologix's cutting-edge autologous biologic technologies that allows Bioventus to expand their product portfolio with the addition of this innovative PRP platform.